Sponsor or institution
Clinical trials and research at Guangzhou FineImmune Biotechnology Co., LTD.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Guangzhou FineImmune Biotechnology Co., LTD. that are recruiting, in China. By phase: Phase 1 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Super CAR-T therapy for GPC3-positive advanced liver cancer | Phase 1 | Guangzhou, Gaungdong | Recruiting | Mar 25, 2026 |
| Super1 TCR-T for NY-ESO-1–positive advanced solid tumors | Phase 1 | Guangzhou, Gaungdong | Recruiting | Apr 24, 2025 |
| Injecting T-cells from tumor-associated lymph nodes in patients with advanced solid tumors | Phase 1 | Guangzhou, Gaungdong | Recruiting | Dec 4, 2024 |
| T Cell Therapy for Advanced Solid Tumors | Phase 1 | Guangzhou, Gaungdong | Recruiting | Mar 8, 2024 |
All recruiting trials (4)
-
Super CAR-T therapy for GPC3-positive advanced liver cancer
This trial tests a single infusion of Super CAR-T cell therapy in adults with advanced, GPC3-positive hepatocellular carcinoma who have failed at least two standard treatments.
-
Super1 TCR-T for NY-ESO-1–positive advanced solid tumors
This trial tests whether a single infusion of Super1 TCR-T can help people with advanced sarcoma, lung cancer, or melanoma whose tumors are HLA-A*02 positive and express NY-ESO-1.
-
Injecting T-cells from tumor-associated lymph nodes in patients with advanced solid tumors
This study is testing a new treatment that injects special immune cells from lymph nodes into patients with advanced solid tumors like melanoma and lung cancer to see if it helps their bodies fight the cancer better.
-
T Cell Therapy for Advanced Solid Tumors
This study is testing a new T cell therapy for people with advanced solid tumors that haven't responded to other treatments to see if it can help them feel better.
Quick answers
How many clinical trials run by Guangzhou FineImmune Biotechnology Co., LTD. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.